NEW YORK, Sept. 22 /PRNewswire/ -- The 500-attorney national law firm of Edwards Angell Palmer & Dodge announced today that its clients, Takeda Pharmaceutical Company Limited and Takeda Pharmaceuticals North America, Inc., have prevailed in a fees motion involving the patent infringement action against generic drug manufacturers challenging Takeda’s patent on ACTOS(R) (pioglitazone hydrochloride), a popular oral antidiabetic agent. In a 51 page opinion & order, the Honorable Denise J. Cote of the U.S. District Court for the Southern District of New York granted Takeda’s motion for an award of attorney’s fees against Alphapharm Pty. Ltd. and Mylan Laboratories, Inc.
“We are very pleased by this favorable and justified ruling for Takeda and the positive affect it will have on the industry. This was an exceptional case, won with the support of a talented team of lawyers and legal professionals dedicated to protecting intellectual property rights,” said David Conlin, an intellectual property partner with Edwards Angell Palmer & Dodge and the lead attorney representing Takeda.
Edwards Angell Palmer & Dodge filed patent infringement actions against four generic drug manufacturers in response to their filing of Abbreviated New Drug Applications (ANDAs) with the FDA under provisions of the Hatch-Waxman Act, challenging certain of Takeda’s patents relating to ACTOS(R) including U.S. Patent No. 4,687,777, which covers its active ingredient, pioglitazone hydrochloride.
Besides Conlin, the Edwards Angell Palmer & Dodge team included Anthony Viola, litigation partner in the New York office, Barbara Moore and Kathleen Carr, litigation partners in the Boston office, Peter Manso, an intellectual property counsel in the Ft. Lauderdale office, Andre Cizmarik, a litigation counsel in the New York office, and Christopher Silva, Adam Samansky, Scott Weston, Jun Umemuro, Ki O, and Andrew O’Connor, all associates in the Boston office.
The Intellectual Property Group at Edwards Angell Palmer & Dodge LLP has extensive experience over many years in establishing, managing, asserting and defending against intellectual property rights. We have handled essentially all business aspects of patents, trademarks, copyrights, trade secrets and related antitrust issues, for the past 35-plus years. The national law firm of Edwards Angell Palmer & Dodge LLP has more than 500 lawyers offering a full array of legal services to clients worldwide. In addition to a strong practice in Intellectual Property Litigation, the Firm has a special industry- based focus in several areas, including Life Sciences, Private Equity/Venture Capital, Financial Services and Insurance and Reinsurance. Edwards Angell Palmer & Dodge has nine offices in Boston, Ft. Lauderdale, Hartford, New York, Providence, Short Hills (NJ), Stamford, Wilmington, West Palm Beach and a representative office in London. For more information, visit www.eapdlaw.com.
Media Contact: Emily Rosen Junior Account Executive Becker Public Relations 75 Valencia Avenue, Suite 600 Coral Gables, FL 33134 Telephone: 305-444-2181 x232 Email: erosen@beckerpublicrelations.com *For a PDF copy of the motion, see above Contact.
Edwards Angell Palmer & Dodge LLP
CONTACT: Emily Rosen, Junior Account Executive of Becker Public Relations,+1-305-444-2181 x232, or erosen@beckerpublicrelations.com, for EdwardsAngell Palmer & Dodge LLP
Web site: http://www.eapdlaw.com//
